Ratio of adult prostate cancer patients enrolled in clinical trials to number of incident cases, by disease site, four most common cancers and all cancers† — 2013 enrolment year
* Suppressed due to small numbers.
"-" Data not available.
Incident cases are estimated for 2013 from the Canadian Cancer Society's Canadian Cancer Statistics.
Data source: Provincial cancer agencies; Canadian Cancer Society, Canadian Cancer Statistics.
* Suppressed due to small numbers.
"-" Data not available.
Incident cases are estimated for 2013 from the Canadian Cancer Society's Canadian Cancer Statistics.
Data source: Provincial cancer agencies; Canadian Cancer Society, Canadian Cancer Statistics.
The adult clinical trial indicator is a ratio not a rate. As such, the numerator is not a complete subset of the denominator. Cases included in the numerator could have been diagnosed in previous years and could be recurrent cases. The numerator is the total number of adult cancer patients (aged 19+) newly enrolled in all phases of therapeutic clinical trials or research studies (radiation, systemic and surgery trials only; curative, adjuvant/neoadjuvant or palliative) at provincial cancer centres in 2013. The denominator is the number of cancer incident cases in 2013. The projected cancer incident cases reported by the Canadian Cancer Society (CCS) were used for the purpose of this proxy indicator only; they should not be compared with the long-term outcomes incident cases.
The Alberta Clinical Trials (ACCT) database includes patients who were living outside Alberta, as long as they were enrolled in a clinical trial taking place in Alberta.
Adult clinical trial participation by disease site
Definition: The ratio of the total number of adult patients (aged 19 and older) newly enrolled in cancer-related therapeutic trials or clinical research studies in 2013 to the projected number of new cancer cases (all ages) in 2013
Numerator: Number of cancer patients (aged ≥19) newly enrolled in cancer-related therapeutic clinical trials or clinical research at provincial cancer centres in 2013. For patients enrolled in multiple clinical trials, all occurrences are counted.
Denominator: Projected number of new invasive cancer cases (all ages) in 2013
Data source: Provincial cancer agencies or equivalent (numerator); Canadian Cancer Society, Canadian Cancer Statistics 2013 (denominator).
Measurement timeframe: 2013 enrolment year
Stratification variables: Disease site: Breast (female); 2. Prostate; 3. Colorectal; 4. Lung; 5. All invasive cancers (the numerator includes all invasive cancers; the denominator consists of all invasive cancers including in-situ bladder cancer cases).
Province-specific notes: AB: For 2013, the total number of accruals for cancer patients (aged ≥19) included newly enrolled patients in cancer-related therapeutic trials or clinical research who were in the Alberta Cancer Clinical Trials (ACCT) database. If a patient had multiple clinical trial accruals in the given year, a patient would be counted for each accrual. The ACCT database also includes patients who were living outside of Alberta, as long as they were on a clinical trial in Alberta. The ACCT database includes both females and males in the Breast Tumour Group and may include clinical trials for non-melanoma skin patients.
General notes:
“All cancers” may include non-melanoma skin patients.
Incident cases are estimated for 2013, obtained from the Canadian Cancer Statistics.
Adult clinical trial participation for prostate cancer
Definition: The ratio of the total number of prostate cancer patients (aged 19 and older) newly enrolled in cancer-related therapeutic trials or clinical research studies in 2013 to the projected number of new prostate cancer cases (all ages) in 2013
Numerator: Number of prostate cancer patients (aged ≥19) newly enrolled in prostate cancer-related therapeutic clinical trials or clinical research at provincial cancer centres in 2013. For patients enrolled in multiple clinical trials, all occurrences are counted.
Denominator: Projected number of new invasive prostate cancer cases (all ages) in 2013
Data source: Provincial cancer agencies or equivalent (numerator); Canadian Cancer Society, Canadian Cancer Statistics 2013 (denominator).
Province-specific notes: AB: For 2013, the total number of accruals for cancer patients (aged ≥19) included newly enrolled patients in cancer-related therapeutic trials or clinical research who were on the Alberta Cancer Clinical Trials (ACCT) database. If a patient went on multiple clinical trial accruals in the given year, a patient would be counted for each accrual. The ACCT database also includes patients who were living outside of Alberta, as long as they were on a clinical trial in Alberta.
General notes:
Incident cases are estimated for 2013, obtained from the Canadian Cancer Statistics.
Per capita investment (male population) in prostate cancer research, by province — 2005 and 2012
Adult clinical trial participation
Ratio of adult patients (aged 19+) enrolled in clinical trials to the number of cancer incident cases of all cancers, by jurisdiction — 2012 to 2015 enrollment years
Cancer research investment
Comparison of the relative burden of disease to the relative investment in research by disease site: Distribution of cancer research investment (2013), new cancer cases (2012) and cancer deaths (2011), by disease site, Canada
